Mark Holdbrook's Insider Trades & SAST Disclosures

Mark Holdbrook's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 198 Common Stock done at an average price of $12.6 . Disclosure was reported to the exchange on March 17, 2023.

Share

Note

This is a custom search result for pattern Mark Holdbrook.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Sale of securities on an exchange or to another person at price $ 12.61 per share.	17 Mar 2023	198	3,191	-	12.6	2,497	Common Stock
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Sale of securities on an exchange or to another person at price $ 13.28 per share.	17 Mar 2023	188	3,389	-	13.3	2,497	Common Stock
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2023	2,653	7,959	-		-	Restricted Stock Units
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2023	2,653	3,764	-		-	Common Stock
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Sale of securities on an exchange or to another person at price $ 13.43 per share.	15 Mar 2023	187	3,577	-	13.4	2,511	Common Stock
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2022	36,173	36,173	-		-	Stock Option (right to buy)
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2022	10,612	10,612	-		-	Restricted Stock Units
Tarsus Pharmaceuticals Inc Board Meeting	Mark Holdbrook	V.P., Clinical Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2021	14,300	14,300	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades